Bax and APPL1 are involved in DCC-ADD induced colorectal ...

Acknowledgement
This study was supported by the National Natural
Science Foundation of China (No. 30801354 and
References
Banerjee AK. DCC expression and prognosis in colorectal
cancer. Lancet. 1997 Apr 5;349(9057):968.
Bernet A, Mehlen P. Dependence receptors: when apoptosis
controls tumor progression. Bull Cancer. 2007
Apr;94(4):E12-7.
Castets M, Broutier L, Molin Y, Brevet M, Chazot G, Gadot N,
Paquet A, Mazelin L, Jarrosson-Wuilleme L,
Scoazec JY, Bernet A, Mehlen P. DCC constrains
tumour progression via its dependence receptor
activity. Nature. 2011 Dec 11;482(7386):534-7.
Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert
JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler
KW, et al. Identification of a chromosome 18q gene
that is altered in colorectal cancers. Science. 1990
Jan 5;247(4938):49-56.
Forcet C, Ye X, Granger L, Corset V, Shin H, Bredesen DE,
Mehlen P. The dependence receptor DCC (deleted in
colorectal cancer) defines an alternative mechanism
for caspase activation. Proc Natl Acad Sci U S A.
2001 Mar 13;98(6):3416-21.
Gal R, Sadikov E, Sulkes J, Klein B, Koren R. Deleted in
colorectal cancer protein expression as a possible
predictor of response to adjuvant chemotherapy in
colorectal cancer patients. Dis Colon Rectum. 2004
Jul;47(7):1216-24.
Goyette MC, Cho K, Fasching CL, Levy DB, Kinzler KW,
Paraskeva C, Vogelstein B, Stanbridge EJ.
Progression of colorectal cancer is associated with
multiple tumor suppressor gene defects but inhibition
of tumorigenicity is accomplished by correction of
any single defect via chromosome transfer. Mol Cell
Biol. 1992 Mar;12(3):1387-95.
Horstmann MA, Pösl M, Scholz RB, Anderegg B, Simon P,
Baumgaertl K, Delling G, Kabisch H. Frequent
reduction or loss of DCC gene expression in human
osteosarcoma. Br J Cancer. 1997;75(9):1309-17.
Gene Therapy and Molecular Biology Vol 14, page 59
61
30970791) and the Fundamental Research Funds
(201103234) from Jilin University, China
Lalier L, Cartron PF, Juin P, Nedelkina S, Manon S, Bechinger
B, Vallette FM. Bax activation and mitochondrial
insertion during apoptosis. Apoptosis. 2007
May;12(5):887-96.
Liu J, Yao F, Wu R, Morgan M, Thorburn A, Finley RL Jr,
Chen YQ. Mediation of the DCC apoptotic signal by
DIP13 alpha. J Biol Chem. 2002 Jul
19;277(29):26281-5.
Mazelin L, Bernet A, Bonod-Bidaud C, Pays L, Arnaud S,
Gespach C, Bredesen DE, Scoazec JY, Mehlen P.
Netrin-1 controls colorectal tumorigenesis by
regulating apoptosis. Nature. 2004 Sep
2;431(7004):80-4.
Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen
GS, Bredesen DE. The DCC gene product induces
apoptosis by a mechanism requiring receptor
proteolysis. Nature. 1998 Oct 22;395(6704):801-4.
Mehlen P, Fearon ER. Role of the dependence receptor DCC in
colorectal cancer pathogenesis. J Clin Oncol. 2004
Aug 15;22(16):3420-8.
Narayanan R, Lawlor KG, Schaapveld RQ, Cho KR,
Vogelstein B, Bui-Vinh Tran P, Osborne MP, Telang
NT. Antisense RNA to the putative tumor-suppressor
gene DCC transforms Rat-1 fibroblasts. Oncogene.
1992 Mar;7(3):553-61.
Renault TT, Manon S. Bax: Addressed to kill. Biochimie. 2011
Sep;93(9):1379-91.
Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER,
Steele G Jr, Jessup JM, Loda M, Summerhayes IC.
The DCC protein and prognosis in colorectal cancer.
N Engl J Med. 1996 Dec 5;335(23):1727-32.
Saito M, Yamaguchi A, Goi T, Tsuchiyama T, Nakagawara G,
Urano T, Shiku H, Furukawa K. Expression of DCC
protein in colorectal tumors and its relationship to
tumor progression and metastasis. Oncology.
1999;56(2):134-41.
Tanaka K, Oshimura M, Kikuchi R, Seki M, Hayashi T,
Miyaki M. Suppression of tumorigenicity in human
colon carcinoma cells by introduction of normal
chromosome 5 or 18. Nature. 1991 Jan
24;349(6307):340-2.
Qingwei Zhou Ph.D Zhongyi Cong Ph.D